Armata Pharmaceuticals, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Armata Pharmaceuticals, Inc. (ARMP) is 0.64

According to Armata Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.64. This represents a change of 27.57% compared to the average of 0.51 of the last 4 quarters.

Armata Pharmaceuticals, Inc. (ARMP) Historical Current Ratio (quarterly & annually)

How has ARMP Current Ratio performed in the past?

The mean historical Current Ratio of Armata Pharmaceuticals, Inc. over the last ten years is 1.76. The current 0.64 Current Ratio has changed 3.57% with respect to the historical average. Over the past ten years (40 quarters), ARMP's Current Ratio was at its highest in in the March 2022 quarter at 7.82. The Current Ratio was at its lowest in in the June 2025 quarter at 0.06.

Armata Pharmaceuticals, Inc. (ARMP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Armata Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Armata Pharmaceuticals, Inc. (ARMP) Average Current Ratio

How has ARMP Current Ratio performed in the past?

The current Current Ratio of Armata Pharmaceuticals, Inc. (ARMP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Armata Pharmaceuticals, Inc. (ARMP) Current Ratio vs. Peers

How is ARMP’s Current Ratio compared to its peers?

Armata Pharmaceuticals, Inc.’s Current Ratio is less than Sangamo Therapeutics, Inc. (0.70), less than Insight Molecular Diagnostics Inc. (2.54), less than C4 Therapeutics, Inc. (9.00), less than Codexis, Inc. (5.36), less than OmniAb, Inc. (4.80), less than Genfit S.A. (2.00), less than Nuvectis Pharma, Inc. (2.27), greater than Neonc Technologies Holdings, Inc. (0.08), less than SELLAS Life Sciences Group, Inc. (17.22), less than Innate Pharma S.A. (1.27),

Build a custom stock screener for Armata Pharmaceuticals, Inc. (ARMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Armata Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Armata Pharmaceuticals, Inc. (ARMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Armata Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.